1-20 of 28
Elizabeth-Garrett Mayer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT268: Palbociclib (P) in patients (pts) with solid tumors with CCND1 amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Ramya Thota, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Tareq Al Baghdadi, Evan Pisick, Olatunji B. Alese, Herbert L. Duvivier, Ajjai S. Alva, Apar Kishor Ganti, Raghava R. Induru, Apostolia M. Tsimberidou, Mehmet Akce, Navid Hafez, Evthokia Hobbs, Andrew Riddle, Margaret von Mehren, Gina N. Grantham, Abigail Gregory, Dominique C. Hinshaw, Susan Halabi, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT268.
https://doi.org/10.1158/1538-7445.AM2024-CT268
Published: 05 April 2024
View article titled, Abstract CT268: Palbociclib (P) in patients (pts) with solid tumors with <em>CCND1</em> amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Journal Articles

Abstract CT267: Temsirolimus (T) in patients (pts) with solid tumors with AKT1/3 amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Deepti Behl, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Niklas Mackler, Herbert L. Duvivier, Philip J. Gold, Sapna R. Patel, Regan M. Duffy, Lauren A. Mauro, Eugene R. Ahn, Maria Bell, Carmen J. Calfa, Jean L. Grem, Jens Rueter, Margaret von Mehren, Gina N. Grantham, Abigail Gregory, Dominique C. Hinshaw, Susan Halabi, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2024) 84 (7_Supplement): CT267.
https://doi.org/10.1158/1538-7445.AM2024-CT267
Published: 05 April 2024
View article titled, Abstract CT267: Temsirolimus (T) in patients (pts) with solid tumors with <em>AKT1/3</em> amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Journal Articles

Abstract CT226: Crizotinib (C) in patients (pts) with solid tumors with MET amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Kathryn F. Mileham, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Herbert L. Duvivier, Carmen J. Calfa, Carrie L. Dul, Alissa S. Marr, Eugene R. Ahn, Deepti Behl, Michael J. Hall, Inderjit Mehmi, Anu Gaba, Rom Leidner, Mark M. Zalupski, Gina N. Grantham, Abigail Gregory, Susan Halabi, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT226.
https://doi.org/10.1158/1538-7445.AM2023-CT226
Published: 14 April 2023
View article titled, Abstract CT226: Crizotinib (C) in patients (pts) with solid tumors with <em>MET</em> amplification (amp) or mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Journal Articles

Abstract CT231: Temsirolimus (T) in patients (pts) with solid tumors with PTEN mutation (mut): results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Kristopher Wentzel, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Li Ding, Evan Pisick, Mridula Krishnan, Deepti Behl, Olatunji B. Alese, Carmen J. Calfa, Kathrine A. Cooper, Herbert L. Duvivier, Raghava Reddy Induru, Janet C. Ruzich, Song Zhao, Gina N. Grantham, Abigail Gregory, Susan Halabi, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2023) 83 (8_Supplement): CT231.
https://doi.org/10.1158/1538-7445.AM2023-CT231
Published: 14 April 2023
View article titled, Abstract CT231: Temsirolimus (T) in patients (pts) with solid tumors with <em>PTEN</em> mutation (mut): results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Journal Articles

Abstract CT110: Olaparib (O) in patients (pts) with solid tumors with ATM mutation or deletion: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Kathryn F. Mileham, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Eddy S. Yang, Olatunji B. Alese, Angela Jain, Herbert L. Duvivier, Phillip Palmbos, Eugene R. Ahn, Jeanny B. Aragon-Ching, Kathleen W. Beekman, Deepti Behl, Funda Meric-Bernstam, Rodolfo Gutierrez, Amy Sanford, Ramya Thota, Michael Zakem, Song Zhao, Raegan O'Lone, Gina N. Grantham, Susan Halabi, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT110.
https://doi.org/10.1158/1538-7445.AM2022-CT110
Published: 15 June 2022
View article titled, Abstract CT110: Olaparib (O) in patients (pts) with solid tumors with <em>ATM</em> mutation or deletion: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Journal Articles

Abstract CT173: Sunitinib (S) in patients (pts) with metastatic breast cancer (mBC) with FGFR1 mutations or amplifications: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Carmen Calfa, Michael Rothe, Pam K. Mangat, Elizabeth Garrett-Mayer, Eugene Ahn, Keerthi Gogineni, Nitin Rohatgi, Monika L. Burness, Anu Gaba, Omid Hamid, Tareq Albaghdadi, Alison Conlin, Philip Gold, Jordi Rodon, Ramya Thota, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT173.
https://doi.org/10.1158/1538-7445.AM2021-CT173
Published: 01 July 2021
View article titled, Abstract CT173: Sunitinib (S) in patients (pts) with metastatic breast cancer (mBC) with <em>FGFR1</em> mutations or amplifications: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Journal Articles

Abstract CT135: Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reported KRAS, NRAS, BRAF mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Julie Fisher, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Ricardo H. Alvarez, Timothy L. Cannon, Pamela Crilley, Theodore Pollock, Tareq Al Baghdadi, Jared A. Cotta, Andrew L. Rygiel, Kaitlyn R. Antonelli, Samiha Islam, Suanna S. Bruinooge, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT135.
https://doi.org/10.1158/1538-7445.AM2019-CT135
Published: 01 July 2019
View article titled, Abstract CT135: Cetuximab (C) in patients (Pts) with breast cancer (BC) and non-small cell lung cancer (NSCLC) without reported <em>KRAS, NRAS, BRAF</em> mutations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Journal Articles

Abstract CT146: Sunitinib (S) in patients (Pts) with metastatic colorectal cancer (mCRC) with FLT-3 alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Ricardo H. Alvarez, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat, Tareq Al Baghdadi, Eugene R. Ahn, Seungjean Chai, Andrew L. Rygiel, Kaitlyn R. Antonelli, Samiha Islam, Suanna S. Bruinooge, Richard L. Schilsky
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT146.
https://doi.org/10.1158/1538-7445.AM2019-CT146
Published: 01 July 2019
View article titled, Abstract CT146: Sunitinib (S) in patients (Pts) with metastatic colorectal cancer (mCRC) with <em>FLT-3</em> alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Journal Articles

Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells

C. Bryce Johnson, Bennett R. May, Brian P. Riesenberg, Samantha Suriano, Shikhar Mehrotra, Elizabeth Garrett-Mayer, Mohamed L. Salem, Emily K. Jeng, Hing C. Wong, Chrystal M. Paulos, John M. Wrangle, David J. Cole, Mark P. Rubinstein
Journal: Cancer Research
Cancer Res (2018) 78 (11): 3067–3074.
https://doi.org/10.1158/0008-5472.CAN-17-2153
Published: 31 May 2018
View article titled, Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T Cells
Open the PDF for Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8<sup>+</sup> T Cells in another window
Includes: Supplementary data
Journal Articles

Abstract 5474: Sphingosine kinase 2/sphingosine 1-phosphate signaling regulates p16 mediated accelerated aging in normal somatic tissues and tcf21 mediated tumor suppression in lung cancer

Shanmugam Panneer Selvam, Marion Cooley, Kristi Helke, Elizabeth Garrett-Mayer, Charles D. Smith, Besim Ogretmen
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5474.
https://doi.org/10.1158/1538-7445.AM2017-5474
Published: 01 July 2017
View article titled, Abstract 5474: Sphingosine kinase 2/sphingosine 1-phosphate signaling regulates p16 mediated accelerated aging in normal somatic tissues and tcf21 mediated tumor suppression in lung cancer
Journal Articles

Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer

Alessandra Metelli, Bill X. Wu, Caroline W. Fugle, Saleh Rachidi, Shaoli Sun, Yongliang Zhang, Jennifer Wu, Stephen Tomlinson, Philip H. Howe, Yi Yang, Elizabeth Garrett-Mayer, Bei Liu, Zihai Li
Journal: Cancer Research
Cancer Res (2016) 76 (24): 7106–7117.
https://doi.org/10.1158/0008-5472.CAN-16-1456
Published: 15 December 2016
View article titled, Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer
Open the PDF for Surface Expression of TGFβ Docking Receptor GARP Promotes Oncogenesis and Immune Tolerance in Breast Cancer in another window
Journal Articles

Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death

Matthew J. Scheffel, Gina Scurti, Patricia Simms, Elizabeth Garrett-Mayer, Shikhar Mehrotra, Michael I. Nishimura, Christina Voelkel-Johnson
Journal: Cancer Research
Cancer Res (2016) 76 (20): 6006–6016.
https://doi.org/10.1158/0008-5472.CAN-16-0587
Published: 13 October 2016
View article titled, Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death
Open the PDF for Efficacy of Adoptive T-cell Therapy Is Improved by Treatment with the Antioxidant N-Acetyl Cysteine, Which Limits Activation-Induced T-cell Death in another window
Includes: Supplementary data
Journal Articles

Lack of p53 Augments Antitumor Functions in Cytolytic T Cells

Anirban Banerjee, Krishnamurthy Thyagarajan, Shilpak Chatterjee, Paramita Chakraborty, Pravin Kesarwani, Myroslawa Soloshchenko, Mazen Al-Hommrani, Kristina Andrijauskaite, Kelly Moxley, Harinarayanan Janakiraman, Matthew J. Scheffel, Kristi Helke, Kent Armenson, Viswanathan Palanisamy, Mark P. Rubinstein, Elizabeth-Garrett Mayer, David J. Cole, Chrystal M. Paulos, Christina Voelkel-Johnson, Michael I. Nishimura, Shikhar Mehrotra
Journal: Cancer Research
Cancer Res (2016) 76 (18): 5229–5240.
https://doi.org/10.1158/0008-5472.CAN-15-1798
Published: 15 September 2016
View article titled, Lack of <em>p53</em> Augments Antitumor Functions in Cytolytic T Cells
Open the PDF for Lack of <em>p53</em> Augments Antitumor Functions in Cytolytic T Cells in another window
Includes: Supplementary data
Journal Articles

Abstract 1949: Oncogenic signaling in amphiregulin- and EGFR-expressing PTEN-null human breast cancer

Christiana S. Kappler, Stephen T. Guest, Ericka L. Smith, Jonathan C. Irish, Elizabeth Garrett-Mayer, Zachary Kratche, Stephen Ethier
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1949.
https://doi.org/10.1158/1538-7445.AM2015-1949
Published: 01 August 2015
View article titled, Abstract 1949: Oncogenic signaling in amphiregulin- and EGFR-expressing PTEN-null human breast cancer
Journal Articles

Abstract 3736: Assessment of tobacco use within 30 days increases referral for cessation support

Samuel Lewis Cooper, Katherine Hoover, Elizabeth Garrett-Mayer, Kenneth Michael Cummings, Matthew J. Carpenter, Kelly Crowley, David T. Marshall, Graham W. Warren
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3736.
https://doi.org/10.1158/1538-7445.AM2015-3736
Published: 01 August 2015
View article titled, Abstract 3736: Assessment of tobacco use within 30 days increases referral for cessation support
Journal Articles

Abstract CT122: RCT of an herbal mouthrinse for radiotherapy induced oral mucositis in cancer patients

Susan G. Reed, Joan E. Cunningham, Elizabeth Garrett-Mayer, Jennifer L. Mulligan, Laura D. Fields, Lynsey R. Boyle, Sarah P. Daanen, John H. Keller, Casey L. Roach, Whitney C. Pasquini, Lauren Lawrence, Howell Harmon, Ahmad R. Garrett, Michael J. Wargovich, Anand K. Sharma
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): CT122.
https://doi.org/10.1158/1538-7445.AM2015-CT122
Published: 01 August 2015
View article titled, Abstract CT122: RCT of an herbal mouthrinse for radiotherapy induced oral mucositis in cancer patients
Journal Articles

Abstract 1116: Oncogene signatures identify novel therapeutic targets and combinatorial strategies in breast cancer

Stephen Guest, Zachary Kratche, Jonathan Irish, Aliccia Bollig-Fischer, Elizabeth Garrett-Mayer, Stephen Ethier
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1116.
https://doi.org/10.1158/1538-7445.AM2015-1116
Published: 01 August 2015
View article titled, Abstract 1116: Oncogene signatures identify novel therapeutic targets and combinatorial strategies in breast cancer
Journal Articles

Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions

Pravin Kesarwani, Amir A. Al-Khami, Gina Scurti, Krishnamurthy Thyagarajan, Navtej Kaur, Shahid Husain, Quan Fang, Osama S. Naga, Patricia Simms, Gyda Beeson, Christina Voelkel-Johnson, Elizabeth Garrett-Mayer, Craig C. Beeson, Michael I. Nishimura, Shikhar Mehrotra
Journal: Cancer Research
Cancer Res (2014) 74 (21): 6036–6047.
https://doi.org/10.1158/0008-5472.CAN-14-1084
Published: 30 October 2014
View article titled, Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions
Open the PDF for Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions in another window
Includes: Supplementary data
Journal Articles

Abstract 3392: Thromboxane-A2 receptor β-isoform regulates the activity of the tumor suppressor FOXO3 via phosphorylation by ERK in urothelial cancer

Philip M. Sobolesky, Perry V. Halushka, Elizabeth Garrett-Mayer, Omar Moussa
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 3392.
https://doi.org/10.1158/1538-7445.AM2014-3392
Published: 01 October 2014
View article titled, Abstract 3392: Thromboxane-A<sub>2</sub> receptor β-isoform regulates the activity of the tumor suppressor FOXO3 via phosphorylation by ERK in urothelial cancer
Journal Articles

Abstract 440: The TRiC chaperonin in breast cancer cell growth, survival and response to taxane therapy

Stephen Guest, Jon Irish, Zachary Kratche, Elizabeth Garrett-Mayer, Robert Wilson, Stephen Ethier
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 440.
https://doi.org/10.1158/1538-7445.AM2014-440
Published: 01 October 2014
View article titled, Abstract 440: The TRiC chaperonin in breast cancer cell growth, survival and response to taxane therapy